Hot topics close

Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020

CanFite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today it is implementing an interim analysis of the Phas
Similar news
News Archive
  • Karel Gott
    Karel Gott
    Karel Gott dead – Czech singer dubbed the ‘Frank Sinatra of the East’ who sold millions of records dies aged 8
    2 Oct 2019
    3
  • Cancer in dogs
    Cancer in dogs
    Signs of common dog cancer owners need to know about
    4 Feb 2024
    1
  • CocoCay
    CocoCay
    Inclement Weather Continues to Rock The Caribbean Islands
    8 Feb 2024
    1
  • Cortana
    Cortana
    Study suggests personal assistants are “reaching their peak capabilities”
    27 Oct 2019
    3
  • AbbVie
    AbbVie
    AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
    20 Feb 2024
    3
This week's most popular news